Abstract
Allogeneic bone marrow transplantation (BMT) is an effective treatment for Fanconi's anemia (FA) but it requires a dose reduction of alkylating agents used for conditioning because of the increased sensitivity of FA cells to DNA cross-linking agents. Oesophageal damage has not previously been described as a complication after allogeneic BMT for this indication. We report five cases of severe oesophagitis with stenosis in patients transplanted for FA. It occurred either early, or more surprisingly, several years after BMT and could have easily been misdiagnosed. It could be explained by hypersensitivity of the FA mucosal cells to cytotoxic agents despite the reduced doses of cyclophosphamide and irradiation or to non diagnosed congenital abnormalities of the oesophagogastric junction. However, the evolution of the oesophageal disease was favorable in all, and none of the patients developed secondary cancer. Awareness of this complication will lead to earlier diagnosis and treatment of oesophageal stenosis and related malnutrition. Bone Marrow Transplantation (2000) 26, 215–218.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
D'Andrea AD, Grompe M . Molecular biology of Fanconi anemia: implications for diagnosis and therapy Blood 1997 90: 1729–1736
Young NS, Alter BP . Clinical features of Fanconi's anemia. In: Young NS, Alter BP (eds) Aplastic Anemia Acquired and Inherited Saunders: Philadelphia 1994 275–309
Giampietro PF, Adrerbrecher B, Verlander PC et al. The need for more accurate and timely diagnosis in Fanconi anemia. A report of the International Fanconi Anemia Registry Pediatrics 1993 91: 1116–1120
Berger R, Bernheim A, Gluckman E . In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi's anemia patients Br J Haematol 1980 45: 565–568
Auerbach AD . Fanconi anemia diagnosis and the diepoxybutane (Deb) test Exp Hematol 1993 21: 731–733
Seyschab H, Friedl R, Sun Y et al. Comparative evaluation of diepoxybutane sensitivity and cell cycle blockage in the diagnosis of Fanconi anemia Blood 1995 85: 2233–2237
Miglierina R, Le Coniat M, Gendron M, Berger R . Diagnosis of Fanconi's anemia by flow cytometry Nouv Rev Fr Hematol 1990 32: 391–393
Gluckman E, Auerbach AD, Horowitz MM et al. Bone marrow transplantation for Fanconi anemia Blood 1995 86: 2856–2862
Socie G, Devergie A, Girinski T et al. Transplantation for Fanconi's anaenmia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning Br J Haematol 1998 103: 249–255
Socie G, Gluckman E, Raynal B et al. Bone marrow transplantation for Fanconi anemia using low-dose cyclo-phosphamide/thoracoabdominal irradiation as conditioning regimen: chimerism study by the polymerase chain reaction Blood 1993 82: 2249–2256
Flowers ME, Zanis J, Pasquini R et al. Marrow transplantation for Fanconi anaemia: conditioning with reduced doses of cyclophosphamide without radiation Br J Haematol 1996 92: 699–702
Guardiola P, Pasquini R, Dokal I et al. for the Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation group and the European Fanconi Anemia Registry Outcome of 69 allogeneic stem cell transplantation for Fanconi anemia using HLA-matched unrelated donors. A study on behalf of the European Group for Blood and Marrow Transplantation Blood 2000 95: 422–429
Perel Y, Butenandt O, Carrere A et al. Oesophageal atresia, VACTERL association: Fanconi's anemia related spectrum of anomalies Arch Dis Child 1998 78: 375–376
Porteous MEM, Cross I, Burn J . VACTERL with hydrocephalus: one end of the Fanconi spectrum of anomalies Am J Med Genet 1992 43: 502–508
McDonald GB, Schulman HM, Sullivan KM, Spencer GD . Intestinal and hepatic complications of human bone marrow transplantation. Part I Gastroenterology 1986 90: 460–477
McDonald GB, Schulman HM, Sullivan KM, Spencer GD . Intestinal and hepatic complications of human bone marrow transplantation. Part II Gastroenterology 1986 90: 770–784
Stemmelin GR, Pest P, Peters RA et al. Severe oesophageal stricture after autologous bone marrow transplant (letter) Bone Marrow Transplant 1995 15: 1001–1002
Meyers JD, Flournoy N, Thomas ED . Infection with herpes simplex virus and cell-mediated immunity after marrow transplant J Infect Dis 1980 142: 338–346
Smith PM, Kerr GD, Cockel CR et al. A comparison of omeprazole and ranitidine in the prevention of recurrence of benign oesophageal stricture. Restore Investigator Group Gastroenterology 1994 107: 1312–1318
Deeg HJ, Socié G, Schoch G et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients Blood 1996 87: 386–392
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yakoub-Agha, I., Damaj, G., Garderet, L. et al. Severe oesophagitis after allogeneic bone marrow transplantation for Fanconi's anemia. Bone Marrow Transplant 26, 215–218 (2000). https://doi.org/10.1038/sj.bmt.1702469
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702469